SB to Buy Block Drug for 1 24
Selected Abstract
SB to Buy Block Drug for $1.24 Bn To Strengthen Consumer Health.(SmithKline Beecham Corp., Block Drug Company Inc.)(Brief Article)
IN A MOVE to strengthen its consumer healthcare portfolio, SmithKline Beecham (SB) has agreed to acquire Block Drug Company Inc. for $1.24 billion. Block Drug manufactures Sensodyne toothpaste and other oral healthcare and consumer products. Block has been on the block since June, when the company ... October 16, 2000; Chemical Market Reporter
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
SB to Buy Block Drug for $1.24 Bn To Strengthen Consumer Health.(SmithKline Beecham Corp., Block Drug Company Inc.)(Brief Article)
|
